We determined the presence of antibiotic-resistant enterococci (ARE) in commercialized poultry samples from Portugal and analysed their clonal diversity and the resistance genes harboured by these strains.
Introduction
The increase in antibiotic-resistant enterococci (ARE) recovered from animal production, food products and non-hospitalized patients during the 1990s raised concern about the medical consequences of selection of resistance caused by the use of antibiotics for growth enhancement in animal production. This fear has led to the progressive ban of antibiotic growth promoters in the European Union. 1 Dissemination of ARE occurs through the spread of particular strains and/or different mobile elements carrying antibiotic resistance genes. 1, 2 In poultry production, the risk of spread of such enterococci is enhanced as only a few different genetic lines of primary breeding flocks are sold by a reduced number of suppliers. This limits the host diversity and, because of the increased market globalization, the spread of specific clones and elements is facilitated.
Local maintenance of specific antibiotic-resistant strains and/or genetic units associated with poultry has been demonstrated in countries without apparent antibiotic selection. 3 However, little is known about the occurrence of genetically characterized ARE from animals after the growth promoter ban in most European 
Materials and methods

Bacterial strains and sample processing
Between September 1999 and March 2001, 99 swabs or meat samples from the inner carcass of retail poultry (93 chicken lots and 6 turkey lots) were collected on 42 different days from two different butcher shops and one market in the Porto area. Samples corresponded to 10 different brands widely commercialized throughout Portugal: Brand A (n = 20), B (n = 1), C (n = 10), D (n = 12), E (n = 12), F (n = 3), G (n = 8), H (n = 1), I (n = 5) and J (n = 4). The brand of 23 samples was unknown. They were collected before butcher manipulation or contact with butcher shop surfaces and processed on the same day. Samples were preenriched (37 C for 48 h) in buffered peptone water without antibiotics or brain heart infusion (BHI) broth (Oxoid, Basingstoke, UK) with and without 6 mg/L vancomycin. A 100 mL aliquot was plated onto M-Enterococcus agar (Difco, Detroit, MI, USA) or Slanetz-Bartley media (Oxoid, Basingstoke, UK) with and without 6 mg/L vancomycin, 125 mg/L gentamicin, 1000 mg/L streptomycin or 500 mg/L kanamycin. Plates were incubated at 37 C for 24-96 h. Antibiotic resistance phenotype was confirmed by subculturing on the same selective plates as described. From each sample, only one colony per morphology type and antibiotic susceptibility profile was selected.
Identification, susceptibility and characterization of antibiotic resistance
Susceptibility to 12 antibiotics (quinupristin/dalfopristin from Rhône-Poulenc, Lisbon, Portugal; vancomycin, teicoplanin, ampicillin, tetracycline, erythromycin, ciprofloxacin, chloramphenicol, gentamicin, streptomycin, kanamycin and nitrofurantoin from Sigma Chemical Co., St Louis, MO, USA) was determined by the agar dilution method. 4 Species identification and detection of genes coding for resistance to glycopeptides, aminoglycosides, macrolides or streptogramins were conducted by PCR. 5 
Mating experiments
Conjugation experiments were performed by filter and/or broth mating methods at a 1:10 donor/recipient ratio using Enterococcus faecalis strain JH2-2 and Enterococcus faecium strain GE1 as recipients strains (both are fusidic acid-and rifampicin-resistant, plasmid-free). 5 VRE isolates representing each clone/clonal subtype were used as donors (n = 40). Transconjugants were selected on BHI agar plates containing fusidic acid (25 mg/L), rifampicin (100 mg/L) and vancomycin (6 mg/L) and incubated at 37 C for 24-48 h. Conjugation frequency was expressed as number of transconjugants per donor cells.
PFGE
Clonal relationship was analysed among enterococci harbouring vanA (all species but Enterococcus gallinarum) or aac(6 0 )-aph(2 00 )-Ia (E. faecium and E. faecalis) by PFGE using SmaI as restriction enzyme as previously described. 5 
Results
Bacterial strains and susceptibility background
Enterococci were recovered from 83% of the samples studied (82/ 99 samples, 409 isolates). A high percentage of samples contained enterococci non-susceptible to vancomycin (48%), or highly resistant to gentamicin (HLR-GEN 34%), streptomycin (HLR-STR 32%) or kanamycin (HLR-KAN, 30%). Lack of susceptibility to other antibiotics was considered as co-resistance to those used in selective plates in order to avoid overestimation of results by repeated counting of isolates on different selective media (Table 1) . Co-resistance to tetracycline, erythromycin, ciprofloxacin and quinupristin/dalfopristin was observed in the majority of VRE, HLR-GEN, HLR-STR or HLR-KAN isolates. Interestingly, VRE scarcely showed HLR-GEN or vice versa. E. faecium was more often resistant to vancomycin and E. faecalis were more often resistant to high levels of gentamicin.
Characterization of antibiotic resistance genes
Enterococci non-susceptible to vancomycin (MIC = 8 to ‡256 mg/L) were classified as: (i) VanA phenotype-vanA genotype, (MIC of teicoplanin ‡8 mg/L, 38 samples and 82 isolates); (ii) VanB phenotype-vanA genotype (MIC of teicoplanin £4 mg/L, 13 samples and 16 isolates); and (iii) VanC phenotype-vanC1 genotype (MIC of teicoplanin £4 mg/L, 23 samples and 41 isolates). Some of the samples contained enterococcal isolates exhibiting different Van types. HLR-GEN was detected in enterococci carrying aac(6 0 )-aph(2 00 )-Ia (n = 32 isolates, 24 samples) or both aac(6 0 )-aph(2 00 )-Ia and aph(3 0 )-IIIa (n = 11 isolates, 11 samples). Isolates showing HLR-KAN but not HLR-GEN mainly contained the aph(3 0 )-IIIa gene (30 isolates, 24 samples). We did not detect known genes for HLR-KAN isolates from six samples.
The gene erm(B) was found among both erythromycin-resistant and -susceptible isolates (n = 222/391 isolates, MIC = 0.5 to >32 mg/L). We observed vat(D) in quinupristin/dalfopristinresistant isolates (n = 7/259 non-E. faecalis isolates tested) and vat(E) in both quinupristin/dalfopristin-resistant and -susceptible isolates (n = 14 isolates/259). Simultaneous presence of vat(D) and erm(B) (one E. gallinarum and three Enterococcus spp.), vat(E) and erm(B) (two E. faecalis, three E. faecium and two Enterococcus spp.) or vat(D) and vat(E) (two Enterococcus spp.) was detected. Three isolates susceptible to quinupristin/dalfopristin contained vat(E) but did not present erm(B). We did not identify aph(2 00 )-Ib, aph(2 00 )-Ic, aph(2 00 )-Id, erm(A), erm(C) or mef(A) genes.
Transfer of vancomycin resistance was achieved from one E. faecium to E. faecium GE1 and from one E. faecalis to E. faecalis JH2-2 at a frequency of 10 -7 and 10 -8 transconjugants per donor, respectively.
PFGE
Thirty PFGE types were observed among 98 vanA-carrying isolates (PFGE types 1-30). Some strains were identified in different samples ( Table 2 ): E. faecium types 1 (n = 10 samples/17 isolates), 4 (n = 8/18), 2 (n = 6/11) and 3 (n = 3/4); E. faecalis type 22 (n = 2/3) and Enterococcus spp. types 30 (n = 10/12), 28 (n = 3/5), 29 (n = 2/2) and 21 (n = 2/3). Isolates classified as PFGE type 1 showed either VanA phenotype-vanA genotype (n = 15 isolates) or VanB phenotype-vanA genotype (n = 2). Long-term persistence (2-3 years) was detected in some cases (PFGE types 1, 2, 3, 4, 22 and 29).
High diversity was observed among HLR-GEN isolates (26 types among 42 isolates, PFGE types 31-56). Ten PFGE Vancomycin-resistant isolates E. faecium Variable presence of a given resistance phenotype among isolates belonging to the same PFGE type appears in parentheses. a Antibiotic resistance or b resistance genes were not transferred by conjugation.
Discussion
The frequency of VRE in our study was high but within the range reported in other studies after ‡2 years of the avoparcin ban. 1, 6 Although most of our VRE isolates presented VanA phenotype-vanA genotype, a relatively high percentage of samples showed the VanB phenotype-vanA genotype (13%) which has been mainly described in enterococci from poultry samples. 7 The occurrence of enterococci HLR-GEN was higher than that reported in other European studies. 6 Different genes responsible for this phenotype have been described in poultry from America and Asia, 8 and aac(6 0 )-Ie-aph(2 00 )-Ia is the only one found in the European Union to date. High frequency of resistance to erythromycin, tetracycline, ciprofloxacin and quinupristin/dalfopristin was observed in enterococci from all selective plates. High values of resistance to these antibiotics have been related to the extensive use of quinolones, tetracyclines and streptogramins in animal husbandry. 1 Resistance values to chloramphenicol or nitrofurantoin was unexpected because these antibiotics are not available for veterinary use in Portugal and also enterococci are usually susceptible to these molecules. 1 However, the Portuguese authorities recently detected the illegal use of nitrofurans by several poultry producers which might have selected a resistant population. Genetic linkage to Tn1546 has only been demonstrated in genes coding for macrolides of copper sulphate resistance 1 although co-selection by other agents cannot be ruled out. Since genes encoding resistance to erythromycin, tetracycline, quinupristin/dalfopristin or chloramphenicol are frequently located on multiresistance gene clusters, selection of one or more of these specific genetic elements could explain the persistence of different multiresistance patterns. 2 The lack of linkage between resistance to glycopeptides and gentamicin could be due to a species specificity of particular resistancemediating elements and the remarkable low transferability of vancomycin resistance due to the adaptation of certain transferable elements to particular hosts. Hasman et al. 9 have recently described differences in the stability of plasmids coding for glycopeptide resistance among E. faecium strains, which may explain why some resistance plasmids are not successfully disseminated among animal enterococcal populations.
A relatively high number of enterococcal strains carried erm(B) that was not phenotypically expressed. The antibiotic banning policy is based on the concept that antibiotic-resistant strains should have a biological cost (low fitness) if compared with their susceptible counterparts that consequently would prevail without selection. Compensatory mutations reducing this cost 10 may include loss of expression of the involved genes, explaining the observed phenomenon.
The persistence (>2 years) of particular strains from different commercial brands suggests that a certain number of widely disseminated poultry clones might be relevant in the emergence and successful spread of ARE in animals. A reduced number of different genetic lines of primary breeding flocks might also facilitate the spread of particular host-adapted strains.
In summary, the high occurrence of ARE suggests maintenance of selective pressure by the use of different antibiotics or other substances. The relatively high number of widespread strains might reflect particular environmental/host-adapted enterococcal strains that could contribute to the persistence of antibiotic resistance, constituting a reservoir of non-susceptible isolates non-sensitive to banning interventions.
